血液加温器市场－2026-2031年预测

预计血液加温器市场将从 2025 年的 12.73 亿美元成长到 2031 年的 19.46 亿美元，复合年增长率为 7.33%。

血液加温器市场是医疗设备业的重要组成部分，专注于设计用于在输注前后安全提升血液和静脉输液温度的设备。这些设备对于预防医源性低体温至关重要，医源性低体温是一种严重的併发症，可导致凝血功能障碍、心律不整、药物代谢受损以及术中出血增加。血液加温器的应用场景涵盖多种临床环境，包括医院手术室和加护病房、急诊、创伤护理、救护车服务以及新生儿加护病房。市场成长的驱动因素包括手术全期体温管理作为标准护理措施的日益普及，以及需要快速液体復苏的医疗服务范围不断扩大。

主要市场成长要素

医疗服务和临床实践中的几项平行趋势正在推动市场扩张。其中一个关键驱动因素是全球外科手术数量和复杂性的不断增加。随着手术数量的增加，尤其是在整形外科、心血管外科和移植手术等领域，使用输液加温设备维持正常体温已成为术后早期復健（ERAS）通讯协定中必不可少的环节。临床指引以及对改善病患预后、减少併发症和缩短住院时间的重视，进一步推动了手术室主动加温系统的应用。

与此密切相关的是输血和大量输血通讯协定（MTP）需求的不断增长。在创伤、大型手术和肿瘤治疗中，大量输注冷血製品是导致体温过低的直接原因。在快速输血过程中对这些血液製品进行加温的医疗需求已得到充分证实，这使得在急诊和手术环境中对高流量血液加温系统的需求持续存在。为改善血库管理和输血安全所做的努力进一步凸显了可靠加温装置的必要性。

此外，院前急救医疗服务（EMS）和救护车服务的扩展和专业化构成了一个不断增长的市场领域。在院前环境中，尤其是在创伤和重症监护中，使用血液製品正成为新的常态。这直接催生了对便携式、坚固耐用且易于使用的血液加温装置的需求，这些设备旨在应对行动医疗的挑战，从而推动携带式设备领域的创新和需求成长。

区域展望：亚太地区主导未来

亚太地区有望成为血液加温器的主要市场。该地区庞大的人口规模、快速发展的医疗基础设施以及不断增长的公共和私人医院现代化投资，都为其主导地位提供了支撑。慢性病患者数量增加、医疗支出成长以及对提升临床标准的日益重视，共同造就了该地区庞大且不断扩大的市场潜力。此外，该地区致力于加强急救医疗服务和外科手术能力，使其成为医疗设备普及应用的关键成长引擎。

主要市场限制因素

血液和体液加温系统市场渗透的主要阻碍因素是其高昂的初始资本投入，尤其是在成本敏感型环境和发展中地区。这不仅包括加温主机和耗材的购置价格，还包括维护、校准和人员培训等相关费用。对于资金预算有限的中低收入国家的中小型诊所、区域医院或医疗系统而言，这笔初始成本可能成为推广应用的重大障碍，甚至可能导致这些设备只能在规模更大、资金更充足的三级医疗机构中使用。

竞争格局与产品创新

该市场由大规模医疗技术公司和专业器材製造商组成。竞争主要集中在器械的有效性、安全性、易用性和整体拥有成本等方面。主要产品开发趋势包括：

• 便携性和整合性：为紧急医疗服务 (EMS) 和医院内运输设计紧凑型电池供电加热设备，并将加热功能整合到手术室的各种流体管理系统中。
• 高流量容量：开发能够以非常高的流速（例如，大于 500 mL/min）加热液体的系统，以支援创伤復苏和大量输血通讯协定。
• 安全与监控：采用多个独立温度感测器、气泡侦测器和警报器等先进功能，防止过热并确保病患安全。
• 一次性套装设计：我们正在创新一次性套装，以加快安装速度，减少预充量，并最大限度地降低污染风险。

主要企业的策略重点是透过结果数据证明临床价值，与大型医院集团和门诊护理网络签订合同，并提供全面的服务和支援方案。

未来展望与战略考量

受预防低体温及其併发症这一关键临床需求的推动，血液加温器市场预计将保持稳定成长。未来发展趋势将受到微创手术和门诊治疗发展的影响，这可能会推动对更小巧、更紧凑型加温器的需求。此外，用于数据记录和合规性监测的连接整合也是一个潜在的创新领域。

对于产业相关人员，策略成功取决于开发分层产品系列，既要满足高风险重症医院的需求，又要满足注重成本的细分市场的需求；同时，还要提供可靠的临床证据来支持产品的使用；此外，还需在全球市场中应对各种监管途径。随着主动式患者保暖在所有输液的临床环境中日益成为标准护理措施，血液加温器市场将继续成为现代治疗性体温管理的重要组成部分。

本报告的主要优势：

• 深入分析：获得主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直领域和其他细分市场。
• 竞争格局：了解全球主要企业的策略倡议，并了解透过正确的策略进入市场的可能性。
• 市场驱动因素与未来趋势：探讨影响市场的动态因素和关键趋势及其对未来市场发展的影响。
• 可操作的建议：利用这些见解，在快速变化的环境中製定策略决策，发展新的商业机会和收入来源。
• 受众广泛：适用于Start-Ups、研究机构、顾问公司、中小企业和大型企业，且经济实惠。

以下是一些公司如何使用这份报告的范例

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

报告范围：

• 2021年至2025年的实际数据和2026年至2031年的预测数据
• 成长机会、挑战、供应链前景、法规结构与趋势分析
• 竞争定位、策略和市场占有率分析
• 按业务板块和地区（包括国家）分類的收入和预测评估
• 公司概况（策略、产品、财务资讯、关键发展等）

目录

第一章执行摘要

第二章 市场概览

• 市场概览
• 市场定义
• 调查范围
• 市场区隔

第三章 商业情境

• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析
• 产业价值链分析
• 政策与法规
• 策略建议

第四章 技术展望

第五章 血液加温器市场：依产品分类

• 介绍
• 携带式血液和体液加温装置
• 固定式血液及输液加温装置

第六章 血液加温器市场：依应用领域划分

• 介绍
• 外科手术
• 急性护理
• 新生儿护理
• 居家医疗
• 其他的

第七章 按终端使用者分類的血液加温器市场

• 介绍
• 医院/诊所
• 门诊服务
• 国防部
• 救援队

第八章 各地区血液加温器市场

• 介绍
• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他的
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他的
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他的
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 印尼
  • 泰国
  • 其他的

第九章：竞争格局与分析

• 主要企业和策略分析
• 市占率分析
• 合併、收购、协议和合作
• 竞争对手仪錶板

第十章：公司简介

• Stryker Corporation
• Gentherm Medical
• Belmont Medical
• 3M
• ICU Medical
• Vyaire Medical, Inc.
• The Surgical Company PTM
• Life Warmer
• MEQU
• Thermal Angel
• Bound Tree Medical

第十一章附录

• 货币
• 先决条件
• 基准年和预测年时间表
• 相关人员的主要收益
• 调查方法
• 简称

The blood warmer market, with a 7.33% CAGR, is expected to grow to USD 1.946 billion in 2031 from USD 1.273 billion in 2025.

The blood warmer market is a critical segment within the medical device industry, focused on devices designed to safely raise the temperature of blood and intravenous (IV) fluids prior to or during administration. These devices are essential for preventing iatrogenic hypothermia, a potentially serious complication that can lead to coagulopathy, cardiac arrhythmias, impaired drug metabolism, and increased surgical blood loss. Their applications span multiple clinical settings, including hospital operating rooms and intensive care units, emergency departments, trauma care, ambulance services, and neonatal intensive care. Market growth is propelled by the increasing recognition of perioperative temperature management as a standard of care and the expansion of healthcare services where rapid fluid resuscitation is required.

Primary Market Growth Drivers

Market expansion is driven by several concurrent trends in healthcare delivery and clinical practice. A significant driver is the growing volume and complexity of surgical procedures globally. As surgical caseloads increase, particularly in areas like orthopedics, cardiovascular, and transplant surgery, the standardized use of fluid warmers to maintain normothermia becomes integral to enhanced recovery after surgery (ERAS) protocols. This is reinforced by clinical guidelines and a focus on improving patient outcomes, reducing complications, and shortening hospital stays, all of which support the adoption of active warming systems in operating rooms.

Closely related is the rising demand for blood transfusions and massive transfusion protocols (MTP). In trauma, major surgery, and oncology, the administration of large volumes of cold blood products is a direct cause of hypothermia. The medical imperative to warm these products during rapid infusion is well-established, creating consistent demand for high-flow blood warming systems in emergency and surgical settings. Initiatives to improve blood bank management and transfusion safety further underscore the need for reliable warming equipment.

Furthermore, the expansion and professionalization of pre-hospital emergency medical services (EMS) and ambulance services represent a growing market segment. The deployment of blood products in pre-hospital settings, particularly for trauma and critical care transport, is an emerging standard. This creates a direct need for portable, rugged, and easy-to-use blood warmers designed for the challenges of mobile healthcare, driving innovation and demand in the portable device category.

Geographical Outlook: Asia-Pacific Leadership

The Asia-Pacific region is expected to emerge as the dominant market for blood warmers. This anticipated leadership is fueled by the region's massive population base, rapidly improving healthcare infrastructure, and significant public and private investments in hospital modernization. The increasing prevalence of chronic diseases requiring surgical intervention, alongside rising healthcare expenditures and a growing emphasis on improving clinical standards, creates a substantial and expanding addressable market. The region's focus on enhancing emergency medical services and surgical capacity positions it as the primary growth engine for device adoption.

Key Market Restraint

A primary restraint on market penetration, particularly in cost-sensitive environments and developing regions, is the high initial capital investment required for blood and fluid warming systems. This includes not only the purchase price of the warming consoles and disposable sets but also costs associated with maintenance, calibration, and staff training. For smaller clinics, rural hospitals, or healthcare systems in low- and middle-income countries with constrained capital budgets, this upfront cost can be a significant barrier to adoption, potentially limiting the use of these devices to larger, better-funded tertiary care centers.

Competitive Landscape and Product Innovation

The market is served by a mix of large, diversified medical technology companies and specialized device manufacturers. Competition centers on device efficacy, safety features, ease of use, and total cost of ownership. Key product development trends include:

• Portability and Integration: Designing compact, battery-operated warmers for EMS and intra-hospital transport, as well as integrating warming functions into broader fluid management systems for the operating room.
• High-Flow Capability: Developing systems capable of warming fluids at very high flow rates (e.g., >500 mL/min) to support trauma resuscitation and massive transfusion protocols.
• Safety and Monitoring: Incorporating advanced features such as multiple independent temperature sensors, air bubble detectors, and alarms to prevent overheating and ensure patient safety.
• Disposable Set Design: Innovating in single-use disposable sets to improve setup speed, reduce priming volume, and minimize the risk of contamination.

Strategic focus for leading players involves demonstrating clinical value through outcomes data, securing contracts with large hospital groups and EMS networks, and offering comprehensive service and support packages.

Future Trajectory and Strategic Considerations

The blood warmer market is poised for steady growth, underpinned by the non-negotiable clinical need to prevent hypothermia and its complications. Future evolution will likely be influenced by the trend toward minimally invasive surgery and office-based procedures, which may drive demand for smaller, more compact warmers. Additionally, the integration of connectivity for data logging and compliance monitoring represents a potential area for innovation.

For industry participants, strategic success will depend on developing tiered product portfolios to address both high-acuity hospital and cost-conscious market segments, providing robust clinical evidence to support utilization, and navigating diverse regulatory pathways across global markets. As the standard of care for active patient warming becomes more deeply entrenched across all clinical settings where fluids are administered, the blood warmer market will remain an essential component of modern therapeutic temperature management.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Blood Warmer Market Segmentation

• By Product
• Portable Blood/IV Warmers Device
• Non-portable Blood/IV Warmers Device
• By Application
• Surgery
• Acute Care
• New Born Care
• Homecare
• Others
• By End-User
• Hospitals/Clinics
• Ambulatory Services
• Defense Forces
• Rescue Forces
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. BLOOD WARMER MARKET BY PRODUCT

• 5.1. Introduction
• 5.2. Portable Blood/IV Warmers Device
• 5.3. Non-portable Blood/IV Warmers Device

6. BLOOD WARMER MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Surgery
• 6.3. Acute Care
• 6.4. New Born Care
• 6.5. Homecare
• 6.6. Others

7. BLOOD WARMER MARKET BY END-USER

• 7.1. Introduction
• 7.2. Hospitals/Clinics
• 7.3. Ambulatory Services
• 7.4. Defense Forces
• 7.5. Rescue Forces

8. BLOOD WARMER MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Stryker Corporation
• 10.2. Gentherm Medical
• 10.3. Belmont Medical
• 10.4. 3M
• 10.5. ICU Medical
• 10.6. Vyaire Medical, Inc.
• 10.7. The Surgical Company PTM
• 10.8. Life Warmer
• 10.9. MEQU
• 10.10. Thermal Angel
• 10.11. Bound Tree Medical

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations